AIM
MED icon

Alambic Investment Management’s Medifast MED Stock Holding History

Alambic Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,008
Closed -$468K – 406
2018
Q1 		$468K Buy
5,008
+196
+4% +$14.6K 0.07% 327
2017
Q4 		$336K Buy
+4,812
New +$319K 0.04% 363
2017
Q2 		– Sell
-9,300
Closed -$413K – 641
2017
Q1 		$413K Sell
9,300
-2,300
-20% -$99K 0.05% 445
2016
Q4 		$483K Sell
11,600
-3,650
-24% -$147K 0.09% 337
2016
Q3 		$576K Buy
15,250
+1,750
+13% +$62.7K 0.14% 257
2016
Q2 		$449K Buy
13,500
+1,200
+10% +$38.7K 0.11% 303
2016
Q1 		$371K Sell
12,300
-3,500
-22% -$102K 0.12% 275
2015
Q4 		$480K Buy
+15,800
New +$471K 0.29% 131

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return